The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
NFβA, a factor required for maximal interleukin-1β gene expression is identical to the ets family member PU.1. Evidence for structural alteration following LPS activation
Abstract
We have previously identified and characterized the macrophage-, neutrophil- and B cell-specific nuclear factor beta A (NF beta A), which is involved in transcriptional regulation of the interleukin-1 beta (IL-1 beta) gene. NF beta A binds to a highly conserved sequence element located 6 bp upstream of the TATA motif within the IL-1 beta promoter and is required for maximal expression of the IL-1 beta gene. Here we show that NF beta A is identical to the previously identified ets gene family member PU.1. The NF beta A binding element shares 100% sequence identity with a novel PU.1 binding element recently found in the immunoglobulin J-chain promoter. Methylation interference DNA footprinting data demonstrated that NF beta A and PU.1 make identical protein/DNA contacts. In vitro synthesized PU.1 possesses a mobility and binding specificity identical to NF beta A as determined by electrophoretic mobility shift analysis (EMSA). Antisera directed against amino acids 39-55 of PU.1 recognizes NF beta A in a manner indistinguishable from PU.1 in EMSA 'supershift' studies. NF beta A and PU.1 also possess similar protein structure as determined by proteolytic clipping bandshift analysis. Furthermore, we show that PU.1 is able to transactivate an NF beta A-dependent promoter when co-transfected into HeLa cells which lack PU.1/NF beta A. EMSA studies using recombinant TATA binding protein (TBP) and PU.1 suggest that PU.1 may induce assembly of a distinct TBP-dependent complex on the IL-…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The block in the development of lymphoid and myeloid lineages in PU.1 mutants occurs at very early stages because the mutant animals completely lack lymphoid and myeloid progenitor cells.
“The block in the development of these lineages occurs at very early stages, because the mutant animals completely lack lymphoid and myeloid progenitor cells, rendering it difficult to determine the precise role of PU.1 during stage- and lineage-specific gene expression.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [73]
Targeted disruption of PU.1 in mice severely impairs the development of lymphoid (B cells) and myeloid (macrophages and neutrophils) lineages.
“Targeted disruption of PU.1 in mice severely impairs the development of lymphoid (B cells) and myeloid (macrophages and neutrophils) lineages.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [73]
Citations
Cites
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
Moreau-Gachelin, F., Tavitian, A., & Tambourin, P. (1988) · Nature · doi:10.1038/331277a0 · Cited by 447
Zhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Macleod, K., Leprince, D., & Stehelin, D. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90404-w · Cited by 304
Hagemeier, C., Bannister, A. J., Cook, A., & Kouzarides, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1580 · Cited by 303
The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter
Pahl, H. L., Scheibe, R. J., Zhang, D. E., Chen, H. M., Galson, D. L., Maki, R. A., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53496-7 · Cited by 301
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 271
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1.
Ray, D., Bosselut, R., Ghysdael, J., Mattei, M. G., Tavitian, A., & Moreau-Gachelin, F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4297 · Cited by 157
Shin, M. K., & Koshland, M. E. (1993) · Genes & Development · doi:10.1101/gad.7.10.2006 · Cited by 126
Flagged first, then by citations
Research works printed but not linked: 27
- Akira, 1990, A nuclear factor for IL-6 expression (NFIL-6) is a member of a CEBP family, Eur. molec. Biol. Org. J., 9, 1897, 10.1002/j.1460-2075.1990.tb08316.x · DOI
- Bensi, 1990, An inducible enhancer controls the expression of the human interleukin 1β gene, Cell Growth Diff., 1, 491
- Bottinger, 1994, The human β2 integrin CD18 promoter consists of two inverted Ets cis elements, Molec. cell. Biol., 14, 2604
- Buras, 1994, The NFβA-binding element, not an overlapping NFIL-6-binding element is required for maximal IL-1β gene expression, J. Immun., 152, 4444, 10.4049/jimmunol.152.9.4444 · DOI
- Clark, 1986, Genomic sequence for human prointerleukin 1β: possible evolution from a reverse-transcribed prointerleukin 1 alpha gene, Nucleic Acids Res., 14, 7897, 10.1093/nar/14.20.7897 · DOI
- Dinarello, 1991, Interleukin 1 and interleukin 1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627 · DOI
- Eichbaum, 1994, Restriction of interferon γ responsiveness and basal expression of the myeloid human FcγR1b gene is mediated by a functional PU.1 site and a transcriptional initiator consensus, J. exp. Med., 179, 1985, 10.1084/jem.179.6.1985 · DOI · Paper page
- Fenton, 1992, Transcriptional and post-transcriptional regulation of interleukin 1 gene expression, Int. J. Immunopharm., 14, 410, 10.1016/0192-0561(92)90170-P · DOI
- Frankel, 1991, Modular structure of transcription factors: implications for gene regulation, Cell, 65, 717, 10.1016/0092-8674(91)90378-C · DOI
- Gardner, 1987, Mouse lymphotoxin and tumor necrosis factor: structural analysis of the cloned genes, physical linkage, and chromosomal position, J. Immun., 139, 476, 10.4049/jimmunol.139.2.476 · DOI
- Gray, 1993, A CREATF-like site in the upstream regulatory sequence of the human IL-1β gene is necessary for induction in U937 and THP-1 monocytic cell line, Molec. cell. Biol., 13, 6678
- Hipskind, 1991, Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF, Nature, 354, 531, 10.1038/354531a0 · DOI
- Hiscott, 1993, Characterization of a functional NF-κB site in the human interleukin 1β promoter: evidence for an autoregulatory loop, Molec. cell. Biol., 13, 6231
- Ho, 1990, Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer, Science, 250, 814, 10.1126/science.2237431 · DOI
- Hunninghake, 1992, The functional importance of a cap site-proximal region of the human prointerleukin 1β gene is defined by viral trans-activation, Molec. cell. Biol., 12, 3439
- Klemsz, 1990, The macrophage and B-cell specific transcription factor PU.1 is related to the ets oncogene, Cell, 61, 113, 10.1016/0092-8674(90)90219-5 · DOI · Paper page
- Luckow, 1987, CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic pomoters and regulatory elements, Nucleic Acids Res., 15, 5490, 10.1093/nar/15.13.5490 · DOI
- Maldonado, 1990, Factors involved in specific transcription by mammalian RNA polymerase II: role of transcription factors IIA, IID, and IIB during formation of a transcription competent complex, Molec. cell. Biol., 10, 6335
- Mavrothalassitis, 1991, Positive and negative factors regulate the transcription of the ETS2 gene via an oncogene-responsive-like unit within the ETS2 promoter region, Cell Growth Diff., 2, 215
- Moulton, 1994, Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif, Molec. cell. Biol., 14, 4408
- Nedwin, 1985, Human lymphotoxin and tumor necrosis factor genes: structure, homology, and chromosomal location, Nucleic Acids Res., 13, 6361, 10.1093/nar/13.17.6361 · DOI
- Petterson, 1987, A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a lymphoid specific factor and contributes to enhancer activity in lymphoid cells, Genes and Dev., 1, 962, 10.1101/gad.1.9.962 · DOI
- Ross, 1994, Comparison of the expression and function of the transcription factor PU.1 (SPI-1 protooncogene) between murine macrophages and B lymphocytes, Oncogene, 9, 121
- Schreiber, 1988, Identification of a novel lymphoid specific octamer binding protein (OFT-2B) by proteolytic clipping bandshift assay (PCBA), Eur. molec. Biol. Org. J., 7, 4221, 10.1002/j.1460-2075.1988.tb03319.x · DOI
- Scott, 1994, Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages, Science, 265, 1573, 10.1126/science.8079170 · DOI · Paper page
- Shirakawa, 1993, The LPS-dependent induction of the human prointerleukin-1 beta gene requires DNA sequences proximal and distal to the transcription start site, Molec. cell. Biol., 13, 1332
- Ziegler-Heitbrock, 1988, Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes, Int. J. Cancer, 41, 456, 10.1002/ijc.2910410324 · DOI
Cited by
Sorted by citations
Ets target genes: past, present and future
Sementchenko, V. I., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204034 · Cited by 371
The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages
Lloberas, J., Soler, C., & Celada, A. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01442-5 · Cited by 142
Marecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111
Self-citationThe Transcription Factor PU.1 is a Critical Regulator of Cellular Communication in the Immune System
Turkistany, S. A., & DeKoter, R. P. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0147-9 · Cited by 96
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87
Self-citationA Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77
PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74
Self-citationRieske, P., & Pongubala, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007482200 · Cited by 54
Lodie, T. A., Reiner, M., Coniglio, S., Viglianti, G., & Fenton, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.268 · Cited by 42
Self-citation
Metadata
- Authors
- Buras, J. A., Reenstra, W. R., & Fenton, M. J.
- Venue
- Molecular Immunology
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 32
- Issue
- 8
- Pages
- 541-554
- ISSN
- 0161-5890
- Cited by
- 23
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review